Article thumbnail

Adeno-Associated Virus-Mediated Gene Transfer to Renal Tubule Cells via a Retrograde Ureteral Approach

By Daniel C. Chung, Ben Fogelgren, Kwon Moo Park, Jessica Heidenberg, Xiaofeng Zuo, Liwei Huang, Jean Bennett and Joshua H. Lipschutz
Topics: Original Paper
Publisher: S. Karger AG
OAI identifier: oai:pubmedcentral.nih.gov:3290852
Provided by: PubMed Central

Suggested articles

Citations

  1. (2005). A realistic chance for gene therapy in the near future. Pediatr Nephrol
  2. A: Human fibroblast growth factor receptor
  3. (2009). Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: a phase 1 dose-escalation trial. Lancet
  4. (1997). AM: Real-time, noninvasive in vivo assessment of adenoassociated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci
  5. (2003). Batshaw ML: Fatal systemic inflammatory response syndrome in an ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab
  6. (2001). Brauchie C: Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science
  7. (2003). Cavazzana-Calvo M: LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science
  8. (2003). CC: Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors.
  9. (2002). Chapman MS: The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci USA
  10. (2001). Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet
  11. (2004). Gene therapy: how to target the kidney. Promises and pitfalls. Curr Gene Ther
  12. (2011). is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999; 5: 71–77. 223 Nephron Extra 2011;1:217–223 DOI: 10.1159/000333071 EXTRA Chung et al.: Renal Gene Delivery Using AAV via a Retrograde Approach www.karger.com/nne ©
  13. (2001). JM: A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors. Mol Ther
  14. (2008). JM: Novel AAV serotypes for improved ocular gene transfer.
  15. (2002). Klotman PE: Lentiviral gene transduction of kidney. Hum Gene Ther
  16. (2004). Kusano E: Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1–5 vectors in vitro and in vivo. Nephron Exp Nephrol
  17. (2000). Remuzzi G: Nonviral and viral gene transfer to the kidney in the context of transplantation. Nephron
  18. (2008). Safety and efficacy of gene transfer for Leber’s congenital amaurosis.
  19. (2010). Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness. Sci Transl Med
  20. (1999). Samulski RJ: V 5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med
  21. (2000). Samulski RJ: Infectious entry pathway of adeno-associated virus and adenoassociated virus vectors.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.